Views & Analysis Digital health round-up: can Xcertia clear the health app co... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News Roche and AC Immune's Alzheimer's drug on right track Data suggest high dose used in phase 3 trial is most effective
News Lilly and AZ begin new Alzheimer's tie-up Companies to develop MEDI1814, building on existing collaboration.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
